| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
5.48(M) |
| Last
Volume: |
4,769,812 |
Avg
Vol: |
4,756,624 |
| 52
Week Range: |
$0.2598 - $0.2598 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
48,285 |
50,285 |
100,872 |
153,373 |
| Total Buy Value |
$98,501 |
$102,221 |
$185,764 |
$224,195 |
| Total People Bought |
6 |
6 |
6 |
6 |
| Total Buy Transactions |
6 |
8 |
17 |
22 |
| Total Shares Sold |
0 |
2,068 |
2,068 |
3,568 |
| Total Sell Value |
$0 |
$4,053 |
$4,053 |
$4,525 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
1 |
1 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Henriksen Ronald D |
Director |
– • – |
2008-11-17 |
4 |
B |
$2.65 |
$13,285 |
D/D |
5,000 |
23,161 |
2.39 |
- |
|
| Henriksen Ronald D |
Director |
– • – |
2008-10-10 |
4 |
S |
$3.00 |
$12,471 |
I/I |
(4,000) |
0 |
|
- |
|
| Henriksen Ronald D |
Director |
– • – |
2008-10-09 |
4 |
B |
$3.81 |
$15,240 |
I/I |
4,000 |
4,000 |
2.1 |
- |
|
| Hedrick Marc H |
President |
• • – |
2008-08-13 |
4 |
B |
$6.59 |
$72,444 |
I/I |
10,800 |
7,800 |
2.66 |
- |
|
| Saad Mark E |
Chief Financial Officer |
• – – |
2008-08-12 |
4 |
B |
$6.63 |
$100,310 |
D/D |
15,000 |
76,500 |
2.74 |
- |
|
| Hedrick Marc H |
President |
• • – |
2008-08-12 |
4 |
B |
$6.72 |
$6,747 |
I/I |
1,000 |
1,000 |
2.58 |
- |
|
| Rickey David |
Director |
– • – |
2008-08-08 |
4 |
OE |
$3.12 |
$41,920 |
D/D |
10,000 |
137,609 |
|
- |
|
| Olympus Corp |
10% Owner |
– – • |
2008-08-07 |
4 |
B |
$6.00 |
$6,000,000 |
D/D |
1,000,000 |
4,013,043 |
2.45 |
- |
|
| Rickey David |
Director |
– • – |
2008-06-20 |
4 |
OE |
$4.40 |
$48,400 |
D/D |
11,000 |
127,609 |
|
- |
|
| Rickey David |
Director |
– • – |
2008-06-18 |
4 |
OE |
$4.16 |
$58,240 |
D/D |
14,000 |
116,609 |
|
- |
|
| Rickey David |
Director |
– • – |
2008-06-17 |
4 |
OE |
$4.16 |
$45,760 |
D/D |
11,000 |
102,609 |
|
- |
|
| Rickey David |
Director |
– • – |
2008-06-16 |
4 |
OE |
$4.16 |
$41,600 |
D/D |
10,000 |
91,609 |
|
- |
|
| Rickey David |
Director |
– • – |
2008-06-13 |
4 |
OE |
$3.12 |
$59,280 |
D/D |
19,000 |
81,609 |
|
- |
|
| Rickey David |
Director |
– • – |
2008-06-11 |
4 |
OE |
$3.12 |
$31,200 |
D/D |
10,000 |
62,609 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2008-06-10 |
4 |
S |
$7.95 |
$443,782 |
D/D |
(53,190) |
100,000 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2008-06-10 |
4 |
OE |
$0.15 |
$7,979 |
D/D |
53,190 |
153,190 |
|
- |
|
| Rickey David |
Director |
– • – |
2008-06-09 |
4 |
OE |
$3.09 |
$77,250 |
D/D |
25,000 |
52,609 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2007-11-28 |
4 |
A |
$5.55 |
$11,106 |
I/I |
2,000 |
15,161 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• – – |
2007-08-22 |
4 |
S |
$5.26 |
$263,000 |
D/D |
(50,000) |
100,000 |
|
- |
|
| Shirahama Norio Seijiro |
Senior VP Asia PacificOfficer |
• – – |
2007-04-05 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• – – |
2006-12-14 |
4 |
B |
$5.01 |
$30,375 |
I/I |
6,000 |
20,000 |
1.99 |
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• – – |
2006-12-13 |
4 |
B |
$4.87 |
$29,220 |
I/I |
6,000 |
14,000 |
1.99 |
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• – – |
2006-12-11 |
4 |
B |
$4.75 |
$19,099 |
I/I |
4,000 |
8,000 |
1.99 |
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• – – |
2006-12-08 |
4 |
B |
$4.64 |
$18,591 |
I/I |
4,000 |
4,000 |
1.99 |
- |
|
| Henriksen Ronald D |
Director |
– • – |
2006-12-04 |
4 |
B |
$4.73 |
$23,650 |
D/D |
5,000 |
18,161 |
2.39 |
- |
|
340 Records found
|
|
Page 10 of 14 |
|
|
